Initial anti-retroviral treatment (therapeutic approach to patients without previous treatment)
Gatell, J.M.; Guerra, L.; Pérez-Elías, M.J.; Santamaría, J.M.
Enfermedades Infecciosas y Microbiologia Clinica 14(Suppl 1): 20-23
1996
ISSN/ISBN: 0213-005X PMID: 9053022 Document Number: 467822
Document emailed within 1 workday
Related Documents
Jost, J. 1990: Current developments in the anti-retroviral treatment of HIV-infected patients Schweizerische Rundschau für Medizin Praxis 79(23): 745-746Ndubuka, N.O.; Ehlers, V.J. 2011: Adult patients' adherence to anti-retroviral treatment: a survey correlating pharmacy refill records and pill counts with immunological and virological indices International Journal of Nursing Studies 48(11): 1323-1329
Boruett, P.; Kagai, D.; Njogo, S.; Nguhiu, P.; Awuor, C.; Gitau, L.; Chalker, J.; Ross-Degnan, D.; Wahlström, R.; Tomson, Göran. 2013: Facility-level intervention to improve attendance and adherence among patients on anti-retroviral treatment in Kenya--a quasi-experimental study using time series analysis Bmc Health Services Research 13: 242
De José Gómez, M.I. 1998: Anti-retroviral treatment of HIV infection in the child Allergologia et Immunopathologia 26(3): 139-144
Villarroya, F.; Domingo, P.; Giralt, M. 2005: Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity Trends in Pharmacological Sciences 26(2): 88-93
De, R.; Bhandari, S.; Roy, S.; Bhowmik, A.; Rewari, B.B.; Guha, S.K. 2013: Factors responsible for delayed enrollment for anti-retroviral treatment Journal of Nepal Health Research Council 11(24): 194-197
Pfeiffer, J. 2011: Pentecostalism and AIDS treatment in Mozambique: creating new approaches to HIV prevention through anti-retroviral therapy Global Public Health 6 Suppl. 2: S163-S173
Jones, P.Sean. 2005: On a never-ending waiting list: toward equitable access to anti-retroviral treatment? Experiences from Zambia Health and Human Rights 8(2): 76-102
Negin, J.; Nyirenda, M.; Seeley, J.; Mutevedzi, P. 2013: Inequality in health status among older adults in Africa: the surprising impact of anti-retroviral treatment Journal of Cross-Cultural Gerontology 28(4): 491-493
Postelmans, L.; Gerard, M.; Sommereijns, B.; Caspers, L.; Clumeck, N.; Libert, J. 1997: Impact of anti-retroviral treatment with protease inhibitors on the evolution of cytomegalovirus retinitis in the patient carrying acquired immunodeficiency syndrome Bulletin de la Societe Belge d'Ophtalmologie 267: 133-144
Bacha, T.; Tilahun, B.; Worku, A. 2012: Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy Bmc Infectious Diseases 12: 197
Paranthaman, K.; Kumarasamy, N.; Bella, D.; Webster, P. 2009: Factors influencing adherence to anti-retroviral treatment in children with human immunodeficiency virus in South India--a qualitative study Aids Care 21(8): 1025-1031
Amouretti, M.; Ansenay, M.; Bader, J.P.; Baillet, J.; Bel, A.; Belaïche, J.; Benzenou, A.; Bertrand, G.; Bonfils, S.; Boucekkine, T. 1985: Efficacy of ranitidine and cimetidine in the treatment of gastric or duodenal ulcer resistant to an initial treatment with cimetidine. Multicenter controlled therapeutic trial Gastroenterologie Clinique et Biologique 9(2): 147-152
Wouters, E.; Heunis, C.; Ponnet, K.; Van Loon, F.; Booysen, F.le.Roux.; van Rensburg, D.; Meulemans, H. 2010: Who is accessing public-sector anti-retroviral treatment in the Free State, South Africa? An exploratory study of the first three years of programme implementation BMC public health 10: 387
Wouters, E.; Heunis, C.; Ponnet, K.; Van Loon, F.; Booysen, F.le.Roux.; van Rensburg, D.; Meulemans, H. 2010: Who is accessing public-sector anti-retroviral treatment in the Free State, South Africa? An exploratory study of the first three years of programme implementation BMC public health 10: 387
Wouters, E.; Heunis, C.; Ponnet, K.; Van Loon, F.; Booysen, F.le.Roux.; van Rensburg, D.; Meulemans, H. 2010: Who is accessing public-sector anti-retroviral treatment in the Free State, South Africa? An exploratory study of the first three years of programme implementation BMC public health 10: 387
Beurton, D.; Pascal, B.; Bronstein, M.; Lepage, T.; Ridoux, G.; Cukier, J. 1979: Medical treatment of ureteral calculi. Therapeutic trial with a synthetic anti-inflammatory agent in 97 patients (proceedings) Journal d'Urologie et de Nephrologie 85(3): 260-264
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
Miyaguchi, S.; Oda, M.; Saito, H.; Ishii, H. 1998: Novel therapeutic approach to primary biliary cirrhosis patients: anti-eosinophil strategy Hepato-Gastroenterology 45(23): 1457-1461
Zaba, B.; Kasamba, I.; Floyd, S.; Isingo, R.; Herbst, K.; Bärnighausen, T.; Gregson, S.; Nyamukapa, C.; Kayuni, N.; Todd, J.; Marston, M.; Wringe, A. 2012: Using age-specific mortality of HIV infected persons to predict anti-retroviral treatment need: a comparative analysis of data from five African population-based cohort studies Tropical Medicine and International Health: Tm and Ih 17(8): E3-14